When AGMB insiders can sell
Agomab Therapeutics NV · IPO prospectus filed 2026-02-06 · Single cliff · 180-day lock-up
That is the calendar date the clause computes to, counted from the prospectus date. It is the only date computable without knowing a future earnings date, which is why everything that could pull it earlier is printed below it on this page rather than folded into it.
The lock-up clause, in the issuer's words
Every other free lock-up calendar tells you 180 days and moves on. This is the actual sentence the date above was computed from, so that if the words do not support the number, the number is wrong and the filing is one click away.
Our directors and executive officers and holders of substantially all of our outstanding securities have entered into lock-up agreements with the underwriters pursuant to which they may not, with certain exceptions, for a period of 180 days from the date of this prospectus, offer, sell or otherwise transfer or dispose of any of our securities, without the prior written consent of representatives of the underwriters. However, representatives of the underwriters may permit our officers, directors and other security holders who are subject to the lock-up agreements to sell common shares or ADSs prior to the expiration of the lock-up agreements at any time in its sole discretion. See the section titled "Underwriting." Sales of these common shares or ADSs, or perceptions that they will be sold, could cause the trading price of the ADSs to decline.
Where the share count comes from
The prospectus never prints the number of shares coming free, and nothing in it lets the figure be derived. That is why this deal carries no flow math.
Exceptions written into the lock-up (4)
Each of these is a route by which AGMB shares can move before 2026-08-05. The 10b5-1 carve-out is the one worth reading twice: it lets insiders put a selling plan in place during the lock-up, so the first sales can be automatic and immediate rather than discretionary and later.
- 10b5-1 plan
- bona fide gift or charitable transfer
- estate planning or family transfer
- option exercise or RSU settlement
Rules on insider trading We have adopted, which became effective upon the effectiveness of the registration statement of which this prospectus forms a part, an internal code on inside dealing and Rule 10b5-1 trading plans by our directors, officers and employees. 191 TABLE OF CONTENTS Code of business conduct and ethics We have adopted a written code of business conduct and ethics, or code of conduct, which outlines the principles of legal and ethical business conduct under which we do business. The code of conduct applies to all of our directors, officers and employees. Upon the closing of this offering, the full text of the code of conduct will be available on our website at www.agomab.com.
…agreements between the underwriters and the lock-up parties do not apply, subject in certain cases to various conditions, to certain transactions, including (a) transfers or dispositions of lock-up securities: (i) as a bona fide gift or gifts, as a charitable contribution or for bona fide estate planning purposes, (ii) by will or intestacy or any other testamentary document, (iii) to any trust for the direct or indirect benefit of the lock-up party or any immediate family member, or if the lock-up party is a trust, to a trustor, trustee (or co-trustee) in their capacity as trustee (or co-trustee, as applicable) or beneficiary of th…
…ts, podiatrists and chiropractors), certain non-physician providers such as physician assistants and nurse practitioners and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Failure to submit required information may result in civil monetary penalties for all payments, transfers of value or ownership or investment interests that are not timely, accurately, and completely reported in an annual submission. 182 TABLE OF CONTENTS Federal government price reporting laws, which will require us to calculate and report complex pricing metrics in an accurate and timely manner to government programs for any approved products in the future.
…k options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of common shares or ADSs or securities convertible into or exercisable or exchangeable for common shares or ADSs (whether upon the exercise of stock options or otherwise) to our employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in effect as of the closing of this offering and described in this prospectus, provided that such recipients enter into a lock-up agreement with the underwriters; iii. our filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect on the date of the underwriting agreement and described in this prospectus or any assumed benefit plan pursuant to an acquisition or similar strategic transaction.
What we could not establish
AGMB is read but not publishable: the prospectus does not state how many shares come free. So there is no absorb-day figure on this page and no call, and there will not be one until the number exists in a filing.
The common case is a prospectus that says "substantially all" of the locked shares become eligible for sale without ever printing a count. The clause above is quoted in full so you can see that for yourself. An estimate presented with a filing link beside it would read as a filing figure, and that is worse than an admission — it is the one failure mode a reader cannot detect.
How this reading of AGMB could be wrong
The lock-up period is restated 5 times in this prospectus. Issuers repeat the clause on the cover, in the summary, in the risk factors and in the underwriting section, and the wording is not always identical. The parser resolved them to one period; if a reader finds a restatement that disagrees, the quote above is the one it used.
The volume is a vendor's, not ours. AGMB is not in our own price table, so average daily volume comes from yahoo-finance2 daily bars (symbol not in our price table). Vendor bars for recently listed symbols are the ones most likely to be wrong.
Only 20 sessions of volume history. This is a recent IPO, and early volume is dominated by the offering itself. An average over 20 sessions of a stock that has barely traded is the weakest input on the page, and absorb days inherits every bit of that weakness.
The parser can misread a filing. That is why every number here is printed next to the words it came from. Earlier versions of this parser read the underwriters' 30-day over-allotment window as a 30-day lock-up on five deals, and double-counted one issuer's share total because the offering summary appears on both the cover and in the summary section.
Also unlocking in 2026-08 (9)
Lock-ups cluster, because IPOs cluster: these priced in the same window as AGMB and come free in the same month. Several heavy releases landing together is a different situation from one.
| Deal | Expiry | Shares free | Absorb days |
|---|---|---|---|
| MANE Veradermics, Inc | 2026-08-03 | 20.0M | 29.9 sessions |
| EIKN Eikon Therapeutics, Inc. | 2026-08-04 | 32.9M | 62.2 sessions |
| BOBS Bob's Discount Furniture, Inc. | 2026-08-04 | 110.9M | 115 sessions |
| SGP SpyGlass Pharma, Inc. | 2026-08-05 | 22.5M | 216 sessions |
| FPS Forgent Power Solutions, Inc. | 2026-08-05 | 287.8M | 25.4 sessions |
| OFRM Once Upon a Farm, PBC | 2026-08-08 | 32.6M | 35.3 sessions |
| MWH SOLV Energy, Inc. | 2026-08-10 | 178.9M | 102 sessions |
| APC ARKO Petroleum Corp. | 2026-08-12 | — | — |
| GENB Generate Biomedicines, Inc. | 2026-08-26 | 102.5M | 102 sessions |
Learn to read these clauses yourself
The flow arithmetic on this page — shares unlocking divided by average daily volume, and why the clause has to be read rather than assumed — taught step by step, free.
Radar built 2026-11-07 from EDGAR full-text search over 424B4 filings · all 80 parsed lock-ups and the scoreboard · AGMB's prospectus on EDGAR · what funds carried these companies at before listing